Literature DB >> 18219498

[Influence of changes to daily dose of opioids on aspects of cognitive and psychomotor performance involved in driving].

J Gaertner1, F Elsner, L Radbruch, F Kolibay, M Theisohn, G Berghaus, H J Gerbershagen, O Dagtekin, R Sabatowski.   

Abstract

INTRODUCTION: It has been shown that long-term treatment with opioids does not necessarily impair driving ability in patients suffering from chronic pain. However, few studies are so far available on how increases in daily opioid dosage affect driving ability.
METHODS: A prospective trial was conducted in patients suffering from chronic noncancer pain, to examine the effects of the daily dose of opioids on psychomotor and cognitive functions. A computerized test system was administered to patients before and 7 days after alteration of their opioid therapy, to determine performance affecting driving ability at each time point. The test design was based on both international and national recommendations for the examination of driving safety.
RESULTS: Raising the daily dose of opioids and/or changing to an opioid at a higher WHO level had no effect on the functions relevant to driving ability in the group context. Pain intensity and serum concentrations of morphine influenced only few items in the test battery.
CONCLUSION: Seven days after an increase in the daily dose of an opioid or after the initiation of opioid therapy there was no general deterioration in patients' driving ability at group level.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18219498     DOI: 10.1007/s00482-007-0620-x

Source DB:  PubMed          Journal:  Schmerz        ISSN: 0932-433X            Impact factor:   1.107


  22 in total

1.  Stable long-term opioid medication per se does not always cause loss of driving ability: the doctor and patient must consider additional risk factors for unsafe driving.

Authors:  H Breivik
Journal:  Acta Anaesthesiol Scand       Date:  2006-07       Impact factor: 2.105

2.  Adverse effects and cognitive function among primary care patients taking opioids for chronic nonmalignant pain.

Authors:  Randall T Brown; Megan Zuelsdorff; Michael Fleming
Journal:  J Opioid Manag       Date:  2006 May-Jun

3.  Chronic pain and driving: proceed with caution.

Authors:  James P Zacny
Journal:  Pain       Date:  2006-03-13       Impact factor: 6.961

4.  Effects of fentanyl and low doses of alcohol on neuropsychological performance in healthy subjects.

Authors:  U Schneider; C Bevilacqua; R Jacobs; M Karst; D E Dietrich; H Becker; K R Müller-Vahl; I Seeland; D Gielsdorf; M Schedlowski; H M Emrich
Journal:  Neuropsychobiology       Date:  1999       Impact factor: 2.328

5.  Cognitive performance, mood and experimental pain before and during morphine-induced analgesia in patients with chronic non-malignant pain.

Authors:  Jürgen Lorenz; Helge Beck; Burkhart Bromm
Journal:  Pain       Date:  1997-12       Impact factor: 6.961

6.  Outcome of chronic opioid therapy for non-cancer pain.

Authors:  J A Haythornthwaite; L A Menefee; A L Quatrano-Piacentini; M Pappagallo
Journal:  J Pain Symptom Manage       Date:  1998-03       Impact factor: 3.612

7.  Effects of opioids on driving ability.

Authors:  T Galski; J B Williams; H T Ehle
Journal:  J Pain Symptom Manage       Date:  2000-03       Impact factor: 3.612

8.  Assessing cognitive and psychomotor performance under long-term treatment with transdermal buprenorphine in chronic noncancer pain patients.

Authors:  Oguzhan Dagtekin; Hans J Gerbershagen; Werner Wagner; Frank Petzke; Lukas Radbruch; Rainer Sabatowski
Journal:  Anesth Analg       Date:  2007-11       Impact factor: 5.108

9.  Long term effects of oral sustained release morphine on neuropsychological performance in patients with chronic non-cancer pain.

Authors:  V Tassain; N Attal; D Fletcher; L Brasseur; P Dégieux; M Chauvin; D Bouhassira
Journal:  Pain       Date:  2003-07       Impact factor: 6.961

10.  The cognitive and psychomotor effects of opioid analgesics. II. A randomized controlled trial of single doses of morphine, lorazepam and placebo in healthy subjects.

Authors:  G W Hanks; W M O'Neill; P Simpson; K Wesnes
Journal:  Eur J Clin Pharmacol       Date:  1995       Impact factor: 2.953

View more
  2 in total

1.  Effect of chronic opioid therapy on actual driving performance in non-cancer pain patients.

Authors:  Markus B Schumacher; Stefan Jongen; Anja Knoche; Frank Petzke; Eric F Vuurman; Mark Vollrath; Johannes G Ramaekers
Journal:  Psychopharmacology (Berl)       Date:  2017-02-12       Impact factor: 4.530

Review 2.  [Cognitive impairment in patients suffering from fibromyalgia. An underestimated problem].

Authors:  T Schmidt-Wilcke; P Wood; R Lürding
Journal:  Schmerz       Date:  2010-02       Impact factor: 1.107

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.